Given how SST plays a major role in the homeostasis of glucose metabolism, inhibiting the release of insulin, glucagon, and incretins, along with the fact that hyperglycemia is a known side effect of the administration of somatostatin analogues (26), this was somewhat surprising. Here, INS is linked to Hyperglycemia.